glp 1 safety Unauthorized GLP-1 Knockoffs Risk Patient and Future Innovation, New PRI Brief Warns Efficacy and Safety of GLP-1

While the exclusion of weight management treatment may limit reimbursement of GLP-1s, non-obesity/overweight diseases such as diabetes mellitus and certain cardiovascular conditions may be eligible for reimbursement because these indications are not excluded

Gastrointestinal side effects from semaglutide (nausea, constipation) are common but temporary and should not prevent you from taking levothyroxine as prescribed

Hormonal balance decreases inflammation, improves immunity, and helps stabilize weight

Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain

Studies in mice with CNS neuron-specific GLP-1R knockout showed that liraglutide failed to induce weight loss but still improved glucose levels, suggesting that brain GLP-1Rs are necessary for the weight-lowering effect of GLP-1RAs but not essential for their glucose-lowering effects (142)